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Introduction: Gold nanorods are highly reactive, have a large surface-to-volume ratio, and
can be functionalized with biomolecules. Gold nanorods can absorb infrared electromagnetic
radiation, which is subsequently dispersed as local heat. Gold nanoparticles can be used as
powerful tools for the diagnosis and therapy of different diseases. To improve the biological
barrier permeation of nanoparticles with low cytotoxicity, in this study, we conjugated gold
nanorods with cell-penetrating peptides (oligoarginines) and with the amphipathic peptide
CLPFFD.
Methods: We studied the interaction of the functionalized gold nanorods with biological
membrane models (liposomes) by dynamic light scattering, transmission electron microscopy
and the Langmuir balance. Furthermore, we evaluated the effects on cell viability and
permeability with an MTS assay and TEM.
Results and Discussion: The interaction study by DLS, the Langmuir balance and cryo-
TEM support that GNR-Arg7CLPFFD enhances the interactions between GNRs and biolo-
gical membranes. In addition, cells treated with GNR-Arg7CLPFFD internalized 80% more
nanoparticles than cells treated with GNR alone and did not induce cell damage.
Conclusion: Our results indicate that incorporation of an amphipathic sequence into
oligoarginines for the functionalization of gold nanorods enhances biological membrane
nanoparticle interactions and nanoparticle cell permeability with respect to nanorods func-
tionalized with oligoarginine. Overall, functionalized gold nanorods with amphipathic argi-
nine rich peptides might be candidates for improving drug delivery by facilitating biological
barrier permeation.
Keywords: gold nanorods, cell-penetrating peptides, amphipathic arginine rich peptide,
liposome, biological barrier permeation
Introduction
Global progress in nanotechnology has led to notable developments in nanomedi-
cine, including new diagnostic systems, drug delivery methods, and a variety of
disease treatments.1–6 One such advancement is represented by gold nanoparticles,
which have a large surface-to-size ratio and are highly reactive.7,8 These properties
allow gold nanoparticle functionalization with synthetic molecules or biomolecules
(eg, antibodies, polymers, drugs, DNA, RNA, and peptides), in addition to facil-
itating biological barrier permeation and, consequently, access to different sites of
interest.2,3,9–11 Gold nanoparticles can also absorb and disperse electromagnetic
radiation as local heat,12,13 specifically by absorbing visible (ie, nanospheres) and
near-infrared (ie, nanorods, nanoshells) radiation, depending on their shape and
size.14–16 Near-infrared radiation can be absorbed by gold nanorods (GNRs), a type
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of gold nanoparticle that may have applications in photo-
thermal therapy for cancer and neurodegenerative
disorders.
Photothermal therapy generates local damage to cancer
cells and the disaggregation of toxic protein aggregates
involved in neurodegenerative diseases, such as
Alzheimer’s disease.17,18 Gold nanospheres and GNRs have
been successfully functionalized with the amphipathic pep-
tide CLPFFD, which recognizes toxic aggregates of amy-
loid-β (TAAβ),19–21 a protein that induces the formation of
amyloid fibrils in plaques present in Alzheimer’s disease.22,23
Moreover, the peptide CLPFFD, due to its amphipathic char-
acter, increases the interactions with the cell membrane,
improving cell penetration of the nanoparticles. Therefore,
the generation of new gold nanoparticle therapies for central
nervous system diseases fundamentally relies on improving
blood-brain barrier penetration, with research particularly
being needed regarding the internalization or biophysical
interactions of gold nanoparticles with biological barriers
and cell membranes.
On the other hand, cell-penetrating peptides (CPPs)
have promising traits that lend to their possible use as
a drug delivery vector,24–26 including low toxicity, high
efficiency for different cell lines and easy adaptation to
drug administration systems. CPPs are short peptide
sequences that comprise a wide diversity of structures.
They can be classified into three groups depending on
their physicochemical properties: cationic, amphipathic or
hydrophobic. The majority of CPPs have a net positive
charge (83%) due to the presence of a high number of
basic residues in their sequence (arginine or lysine). A net
positive charge promotes interactions with negatively
charged membranes, which gives them cellular internaliza-
tion capacities;27 nevertheless, the cellular uptake mechan-
ism has yet to be revealed.28,29 Therefore, CPPs may
enhance the crossing of gold nanoparticles through the
blood-brain barrier. In this regard, some studies have
reported the use of CPPs on the surface of nanoparticles
for brain drug delivery,30,31 eg, the use of gold nanoparti-
cles functionalized with the cell-penetrating peptide TAT,
to increase doxorubicin delivery to brain metastatic breast
cancer cells.32 One kind of CPP is the arginine sequence of
peptides as oligoarginines. However, there are few studies
related to the functionalization of GNRs with oligoargi-
nines. One example is the functionalization of GNRs with
a cysteine-octoarginine peptide to take up activated macro-
phages in autoimmune and inflammatory diseases for
photothermolysis.33
Considering the importance of the primary interaction
between GNRs and the cell membrane for the cell inter-
nalization process, in this work, we conjugated GNRs to
a sequence that contains an oligoarginine and the amphi-
pathic peptide sequence CLPFFD to evaluate whether the
first interaction with the membrane is favored and subse-
quently leads to cell internalization. The positive charges
given by the arginines would promote an interaction with
the negatively charged membranes, while the amphipathic
CLPFFD peptide sequence enables interactions with the
amphipathic phospholipid membrane.
The oligoarginine sequence was conjugated with the
amphipathic peptide CLPFFD20,23,34 to form the construct
RRRRRRRCLPFFD. To promote anchoring onto the sur-
face of the gold nanoparticles, the cysteine residue was
maintained between the two parts of the construct (ie, Arg7
and LPFFD). These peptides showed a “Y shape” on the
GNR surface, with the cysteine residue located at the
lower end of the “Y,” acting as an anchor point for peptide
chemisorption onto the GNR surface.35 In turn, Arg7, with
LPFFD, were located on the upper portion of the “Y”,
a location that would allow for each moiety to interact
with the biological barriers.23
To study the differential effects of the functionalized
sequence components (ie, CPP, the recognition portion, and
the cysteine residue) on the internalization process, GNRs
were conjugated with the peptides CRRRRRRR (CArg7),
RRRRRRRCLPFFD (Arg7CLPFFD), and CLPFFD. Cell
internalization of the conjugates was determined in human
neuroblastoma SH-SY5Y cells. The interactions of the nano-
conjugates were monitored using soybean phosphatidylcho-
line unilamellar lipid vesicles and SH-SY5Y cells. However,
this study did not focus on the cellular internalization
mechanism. Therefore, the Arg7CLPFFD conjugate
increased liposome interactions and SH-SY5Y cellular
uptake without affecting cell viability.
Materials and Methods
Preparation of the Liposomes
Soybean PC (Lipoid S100; PC > 94%) was purchased
from lipoid GmbH (Germany). Lipoid S100 contains
94% PC, and the typical composition related to total
fatty acids is approximately 15% palmitic acid (C16), 4%
stearic acid (C18), 7% oleic acid (18:1), 70% linoleic acid
(18:2), and 6% linolenic acid (18:3).
Liposomes were obtained by hydration (using Milli.Q
water) of the lipidic film formed by rotary evaporation of
Riveros et al Dovepress
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a chloroform lipid mixture. To obtain a defined size (200
nm), the vesicles were extruded by a 10-fold passage
through 800–200 nm polycarbonate membranes.36 The
systems were characterized by dynamic light scattering
(DLS), small angle X-ray scattering (SAXS) and cryo-
transmission electron microscopy (Cryo-TEM) and main-
tained under refrigeration (4 °C) until use.
Synthesis and Conjugation of Gold
Nanorods with the Peptides CLPFFD,
CArg7, Arg7CLPFFD
The peptides were synthesized following protocols pre-
viously described in reference.17 The peptides CLPFFD,
CRRRRRRR (CArg7) and RRRRRRRCLPFFD (Arg7CL
PFFD) were synthesized using a fluorenylmethyloxycar-
bonyl (Fmoc) strategy and solid-phase synthesis. With
this strategy, the peptides were obtained in a sequential
way through the protecting groups Fmoc/tBu. For this
procedure, polypropylene syringes equipped with poly-
propylene porous discs and a polymeric or Rink amide
type resin support (substitution 0.72 mmol/g of resin) and
2- chlorotrityl (0.15 y 0.3 mmol/g of resin) were used.
GNRs were synthesized and conjugated following pro-
tocols described previously in reference.21 Briefly, GNRs
were synthesized using the seed-mediated approach. First,
a seed solution was prepared by reduction of 0.01
M HAuCl4 in a solution of 0.1 M CTAB with 0.01
M sodium borohydride. Next, 0.1 M ascorbic acid was
added to a growth solution with 0.01 M AgNO3, 0.1
M CTAB, and 0.01 M HAuCl4. Then, 0.1 M HCl and
the seed solution were added to the growth solution. The
mixture was allowed to react for 10 min at 27 °C before
centrifugation at 7030 g for 15 min.
For conjugation of the peptides to the GNRs, these were
synthesized as described above, and after the centrifugation
step, the pellets to prepare GNR-CLPFFDwere suspended in
an aqueous peptide solution of 0.25 mg/mL, and the mixture
was allowed to react for 72 h at 27 °C to form a complete
layer of peptide replacing CTAB from the nanomaterial sur-
face. Finally, before the experiments, GNR-peptide and
GNR-CTAB were centrifuged at 1520 g for 60 min.
Finally, the GNRs and GNR-peptide were characterized
by Vis-NIR spectrophotometry, transmission electron
microscopy (TEM), and dynamic light scattering (DLS).
The absorption spectra were recorded at room temperature
with a Perkin Elmer Lambda 25 UV/VIS spectrophot-
ometer. The samples were prepared over formvar carbon-
coated copper microgrids and observed with a JEOL
JEM-1010 transmission electron microscope.
Calculation of the Gold Nanorod
Concentration and Number of Peptide
Molecules per Gold Nanorod
An aliquot of a known volume of GNRs solution was lyo-
philized, and the gold content was determined by neutron
activation analysis (NAA), determining the gold concentra-
tion ([Au]) in the Chilean Nuclear Energy Commission
(CCHEN) as already described.21 With the data of length
and width, the averages of GNR and [Au] were determined
by TEM, and the GNR concentration was determined by the
following equation.37 zaa[GNR] = 4 × [Au]/ρAu × π × W ×
2L, where [GNR] is the GNR concentration, ρAu is the
density of bulk gold atoms (59 atoms/nm3), [Au] is the
gold concentration determined by gold neutron activation,
L is the length of the GNR, and W is the width of the GNR.
To determine the quantity of peptide molecules that are
bound to the GNR-peptide amino acids, an analysis was
performed. Each GNR-peptide sample was hydrolyzed in
6 N HCl with an internal standard (amino butyric acid) for
72 h and then lyophilized. Later, the solution was evapo-
rated under reduced pressure and derivatized for amino
acid analysis by HPLC.
Small Angle X-Ray Scattering (SAXS)
The liposomes were characterized using SAXS. All X-ray
scattering measurements were carried out using an S3-
MICRO (Hecus X-ray systems GMBH Graz, Austria).
X-ray radiation with a wavelength corresponding to a Cu-
Kα source (1.542 Å) was used. A Peltier TCCS-3 (Hecus
GmbH; Graz, Austria) temperature controller and the lin-
ear detector PSD 50 (Hecus; Graz, Austria) were used.
The samples were injected in 1 mm diameter glass capil-
laries (Hilgenberg GmbH; Malsfeld, Germany) as
described in Rodríguez et al.38 The SAXS detector pro-
vides information about the larger structural units in the
sample; namely, the lamellar repeat distance. The curves
are shown as a function of the scattering vector modulus,
Q= (4π sinθ)/λ, in which θ is the scattering angle and Q is
the reciprocal Å. The position of the scattering peaks is
directly related to the repeat distance of the molecular
structure, as described by Bragg’s law.39 In a lamellar
structure, the various peaks are located at equidistant posi-
tions, Qn =2πn/d, where n and d represent the order of the
Dovepress Riveros et al
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diffraction peak and repeat distance, respectively, and Qn
represents the position of the nth order reflection.
Dynamic Light Scattering (DLS)
The hydrodynamic diameter (HD) and polydispersity index
(PDI) of the lipid vesicles, GNR, GNR-peptide and mixes
were determined by DLS using a Zetasizer Nano ZS
(Malvern Instruments, UK). DLS measures the Brownian
motion of the particles and correlates it to the particle size.
The relationship between the size of a particle and its speed
due to Brownian motion is defined in the Stokes-Einstein
equation: D= κT/6πηr, where D is the translational diffusion
coefficient, κ is Boltzmann’s constant, T is the absolute
temperature, η is the viscosity, and r is the particle radius.
The measurements were repeated five times for each sample.
All experiments were performed at 25 °C. Interpretation of
the data was made by considering the size distribution of the
intensity of light scattering. All data were obtained with the
software provided by Malvern Instruments.
Zeta Potential
The zeta potential (Zetasizer nano ZS, Malvern Instruments,
UK) measurements were repeated five times for each GNR
sample. Since the zeta potential measurements were per-
formed in an aqueous solution, the Smolochowski approx-
imation was used to calculate the zeta potential from the
electrophoretic mobility measured.
Cryo-Transmission Electron Microscopy
(cryo-TEM)
GNR-CArg7LPFFD was visualized using cryo-TEM.
A thin aqueous film was formed by dipping and with-
drawing a bare specimen grid from the suspension. Glow-
discharged holey carbon grids were used. After withdrawal
from the suspension, the grid was blotted against filter
paper, which left thin sample films that spanned the grid
holes. These films were vitrified by plunging the grid into
ethane, which was kept at its melting point by liquid
nitrogen, using a Vitrobot40 (FEI Company, Eindhoven,
Netherlands) and keeping the sample at 100% humidity
before freezing. The temperature at which the thin films
were kept and where vitrification was initiated, was 37 °C.
The vitreous sample films were transferred to a Tecnai F20
microscope (FEI Co., Eindhoven, Netherlands) using
a Gatan cryotransfer (Barcelona, Spain). Visualization
was obtained at 200 kV at a temperature between −170
and −175 °C using low-dose imaging conditions.
GNR and GNR-Peptide Interactions with
the Liposome
Interactions between the liposome and each GNR/GNR
peptide were monitored over time using DLS and cryo-
TEM. For this, 0.25 mM liposomes were mixed with 0.5
nM GNR or GNR-peptide in Milli-Q water. All mixtures
were immediately used.
Isotherm of the S100 Phospholipid
Mixture at the Air-Water Interface
A Langmuir balance (Nima Technologies, Ltd., Coventry,
England) with a surface tension precision of 0.1 mN/m and
equipped with a Langmuir Blodgett trough (Model 611)
was used to obtain S100 mixture isotherms. For this, S100
was dissolved in chloroform to a final concentration of
1 mg/mL and spread on the Langmuir trough surface. The
surface pressure (π = γ0 - γ; ie, the surface tension differ-
ence between the clean water surface and the covered
surface) was measured using the Wilhelmy plate method.
Specifically, S100 (8 µL) was spread with a Hamilton
microsyringe on a clean water (18.3 MΩ∙cm) surface or
on different aqueous suspension constructs with GNRs
(final concentration of 3.01 × 109 GNR/mL). All experi-
ments were performed in a dust-free glass box. After sur-
face cleaning and chloroform solution spreading on the
subphase (50 mL), isotherm analyses were performed 15
min after the S100 samples were spread to allow for
chloroform evaporation. When aqueous GNR suspensions
were used as the subphase, isotherm analyses were per-
formed after 1 h. The isotherm analyses were repeated
three times, with an average relative error of 2% when
using a compression rate of approximately 20 cm2/min.
All experiments were performed at 25 °C.
Cell Viability Assay
The SH-SY5Y cell line (from ATCC) was maintained in
DMEM high-glucose medium (GIBCO) containing 10%
inactivated fetal bovine serum (FBS), 100 U/mL penicillin,
and 100 µg/mL streptomycin in a humidified atmosphere of
5% CO2 at 37 °C. To determine the effect of GNRs on
cell viability, a 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxy-
methoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS)
assay was performed to establish a linear relationship
between the viable cell percent and the absorbance. For the
MTS assay, SH-SY5Y cells were seeded in 96-well plates at
3000 cells per well. The cells were then treated with increas-
ing concentrations of GNRs or GNR-peptide. After 24 h of
Riveros et al Dovepress
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incubation, the cell viability was measured (in triplicate) in
three independent experiments using the MTS assay accord-
ing to the manufacturer’s protocol (CellTiter 96® AQueous
Assay, Promega). The absorbance at 490 nm was measured
on amultiscan reader with a referencewavelength of 655 nm.
The use of SH-SY5Y cell line (from ATCC) in Chile
does not require the ethical approbation.
GNR and GNR-Peptide Cell Penetration
Neuroblastoma cells (SH-SY5Y) were incubated with
GNR-peptide for 24 h. Cells were fixed with 3% glutaral-
dehyde in Sörensen phosphate buffer (0.1 M, pH 7.3) and
then kept in fixative medium at 4 °C for 4 h. The cells were
then washed with Sörensen phosphate buffer and postfixed
with 2% osmium tetroxide at 4 °C. The samples were then
dehydrated in acetone, infiltrated with EPON resin for 2
days, embedded in the resin, and polymerized at 70 °C for
48 h. Ultrathin sections were obtained using a Sorvall
Porter-Blum ultramicrotome and mounted on formvar-
coated copper grids. The sections were stained with 2%
uranyl acetate in water and lead citrate and then observed
under a JEM-1010 electron microscope (JEOL, Japan).
Data Analysis
All results are presented as the mean ± SEM from at least
three independent experiments. Statistical analysis of the
data was performed using GraphPad Prism 5 Software.
Kruskal–Wallis statistics followed by Dunn’s post hoc
tests were used and considered significant at p ≤ 0.05.
Results and Discussion
Characterization of GNR-Arg7CLPFFD,
GNR-CArg7 and the Liposomes
To obtain GNR-Arg7CLPFFD, GNRs were incubated with
the peptide Arg7CLPFFD. The peptide Arg7CLPFFD could
be chemisorbed through the thiol contained on the cysteine
to the GNR surface as described previously for the functio-
nalization of GNR with the peptide CLPFFD.21,41 For mod-
ification of the GNR surface, peptides that have a cysteine
residue (C), which contains a thiol group (-SH), allows for
a strong interaction with the gold surface by means of
chemisorption (S - Au).42 The chemisorption of thiols on
the gold surface is a favored process frequently used to
functionalize gold nanoparticles.41 In this way, the CTAB
contained on the surface of the GNR is replaced by the
thiol.21 The peptide-conjugated GNRs were characterized
using TEM, Vis-NIR spectrophotometry, DLS, and amino
acid analyses. The size and aspect ratios of the peptide-
conjugated GNR were obtained by TEM (Figure 1A–C).
The average lengths of GNR-Arg7CLPFFD and GNR-
CArg7, each calculated from 100 nanorods, were 49 ± 1.8
and 43 ± 0.7 nm, respectively. Additionally, the average
widths were 12 ± 0.2 and 12 ± 0.3 nm, respectively. The
median aspect ratio of all conjugates was 4.1, while the
specific average ratios were 4.4 ± 0.9 (GNR-Arg7
CLPFFD) and 3.9 ± 0.8 (GNR-CArg7) (Figure 1A and B).
The spectra obtained were in the near infrared zone, with
a longitudinal surface plasmon resonance centered at 790
nm, compared to the unconjugated GNR, which was cen-
tered at 780 nm (Table 1). This bathochromic shift to
a longer wavelength was consistent with the chemisorption
of the peptides on the GNR surface (Figure 1C), as described
for other peptides conjugated to gold nanoparticles.21
The GNR-peptide size distribution DLS measurements
exhibited two size distribution peaks, one with
a hydrodynamic diameter (Hd) of 3–5 nm and one of
approximately 50 nm with a polydispersity index (PDI)
of 0.4 (Table 1). The small size peak was attributed to the
rotational diffusion of the nanorods instead of the actual
dimension of the nanorods.43
The zeta potentials of GNR-Arg7CLPFFD and GNR-
CArg7 were 37 ± 0.7 and 32 ± 3.5, respectively (Table 1),
without significant differences between them; the positive
values were possibly due to the positive charges of the
peptides at pH 5. In comparison to GNR-CLPFFD (51 ±
1.3) and unconjugated GNR (56 ± 2.9), the GNRs functio-
nalized with Arg7CLPFFD or CArg7 displayed slight
reductions in surface charge, as determined by zeta poten-
tial measurements (Table 1). These effects were most
likely caused by a displacement of the CTAB molecules
that formed the bilayer during functionalization.44
To evaluate the stability of the peptide-conjugated GNR
in the solutions used in the present study, GNR-CLPFFD
and GNR-Arg7CLPFFD were incubated at pH 7 in an
aqueous solution and in cell culture medium (high glucose
DMEM, 10% FBS) at 27 and 37 °C. Samples were periodi-
cally collected over 24 h to obtain the Vis-NIR spectra
(Figure S1). With the exception of GNR-CLPFFD at 24 h,
the plasmon bands of the peptide-conjugated GNRs did not
appreciably change, suggesting that the colloids were stable
at the two tested temperatures.
The peptide loading of each GNR was calculated by
dividing the amount of peptide (obtained by amino acid
analysis of the GNR pellet) by the amount of GNRs in
solution, which was determined by neutron activation
Dovepress Riveros et al
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analysis and considered the TEM obtained diameters (see
the experimental section). There were 909 peptide mole-
cules in GNR-Arg7CLPFFD. Previous studies reported the
conjugation of GNR-CLPFFD with 1812 peptides,21
a load twice that of Arg7CLPFFD. The decreased peptide
load could be explained by the steric hindrance of Arg7
CLPFFD. These peptides were positioned in the “Y” form
on the GNR surface. The bottom portion of this form
corresponded to the Cys residue, which allows for peptide
chemisorption onto the GNR surface. In turn, the oligoar-
ginine and LPFFD chains are exposed to the solvent.
Conversely, CLPFFD was positioned orthogonally to the
GNR surface, thus allowing for the accommodation of
more peptide molecules.
Liposome size, morphology, and structural topology
were characterized by small angle X-ray scattering, DLS,
and cryo-TEM. The size distribution curves of liposomes
at room temperature were visualized (Figure S2A), and
only one peak was observed. This peak centered on
a population with a diameter of 146 ± 0.9 nm and a PDI
of 0.2 (Figure S2A). Cryo-TEM analysis of the
0 1 2 3 4 5 6 7 8 9 10
0
10
20
30
40
50
aspec ratio
grA-
R
N
G
7
tnuoc
GNR-CArg7
0 1 2 3 4 5 6 7 8 9 10
0
10
20
30
40
50
aspec ratio
grA-
R
N
G
7
tnuoc
DFF
PL
C
GNR-Arg7CLPFFD
A B
wavelenght (nm)
400 500 600 700 800 900
)U.A(
ecnabrosba
0,0
0,5
1,0
1,5
2,0
GNR 
GNRCLPFFD 
GNRCArg7
GNRArg7CLPFFD 
C
Figure 1 Characterization of the GNR-peptide. Representative TEM images and insert (histogram of aspect ratio length/width of 100 nanoparticles) of (A) GNR-CArg7 and
(B) GNR-Arg7CLPFFD; (C) Absorption spectrum of GNR and GNR-peptide.
Table 1 Characterization of the GNRs and the GNR-Peptides,
Including the Longitudinal Surface Plasmon Resonance, Zeta
Potential (mV) and Dynamic Light Scattering (d.nm)
GNR-Peptide λ (nm) (Hd)a (d.mn) ZP (mv) a
GNR 790 56 ± 6.9 56 ± 2.9
GNR-CLPFFD 796 56 ± 7.1 51 ± 1.3
GNR-CArg7 789 43 ± 9.0 32 ± 3.5*
,#
GNR-Arg7CLPFFD 802 55 ± 7.6 37 ± 0.7*
,#
Notes: aThe results are shown as the mean ± SEM of five separate experiments in
triplicate, *p < 0.05 with respect to GNR; #p < 0.05 with respect to GNR-CLPFFD.
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morphology revealed predominantly unilamellar lipo-
somes with sizes ranging from 100 to 150 nm (Figure
S2B). Therefore, the data obtained by cryo-TEM and
DLS were consistent. Additionally, small-angle X-ray dif-
fraction patterns for the liposomes showed two reflections,
a result most likely associated with the first and second-
order Bragg distances (d = 6.1 nm) of ordered unilamellar
structures (Figure S2C).
Membrane Model Interactions with GNRs
To evaluate whether oligoarginine CPPs increase the ability
of GNRs to cross biological membranes, the interactions
were observed between the conjugates and liposomes,
a biological membrane model.
First, we used dynamic light scattering (DLS) to identify
the different representative peaks of liposomes and peptide-
conjugated GNR and monitor the nanoparticle intensity
distribution (percent) or size change. For this study, under
kinetic conditions, the liposomes (0.25 mM) were mixed
with peptide-conjugated GNRs or unconjugated GNRs (0.5
nM), and intensity curves vs Hd were measured at different
incubation times over 24 h. Three peaks were observed
(Figure 2). These peaks were centered at approximately
3–5 nm and 50 nm, which were associated with GNRs
size,43 and 150 nm, associated with liposome size. Neither
the control GNRs nor the GNR-CLPFFD conjugate pre-
sented considerable changes over time (Figure 2A and B).
However, when GNRs were conjugated with oligoarginine
(GNR-CArg7 and GNR-Arg7CLPFFD), the peaks (3–5 nm)
for GNR-CArg7 were reduced after 3 h of incubation
(Figure 2C), and the representative peaks for GNR-Arg7
CLPFFD (3–5 and 50 nm) decreased over time (Figure 2D).
Figure 2 Interaction of liposomes with nanoparticles by average dynamic light scattering over time. Representative spectrum of % intensity vs d.nm over time (0–24 h) of
(A) GNR; (B) GNR-CLPFFD; (C) GNR-CArg7 and (D) GNR-Arg7CLPFFD.
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With the purpose of simplifying this analysis, high-
resolution spectra were obtained and expressed as
a percent of the fitted peak areas (Table S1) for both
GNRs peaks (3.5 nm and 50 nm). Figure 3 shows the
fitted peak areas (%) of the GNR centered at approxi-
mately 3.5 nm.
For the first peaks (3–5 nm), GNR-Arg7CLPFFD
decreased 80% at time 3 h (Figure 3A, Table S1) with
respect to time zero, and after 24 h of incubation, the fitted
peak areas (%) were close to zero (Figure 3A). Moreover
for the peak at 50 nm the intensity decreased by 50% at
3h. However, for GNR-CArg7 clear diminution of inten-
sity was observed only for the peak at 50 nm at time
3 h (Figure 3B).
This can be interpreted as the integration of the GNR-
Arg7CLPFFD with the liposomes, either covering the lipid
bilayer or entering the inner portion of the liposome. These
results allow us to postulate that the conjugation of GNR
with oligoarginine peptides leads to enhanced interactions
with lipid membranes. Nevertheless, it is important to note
that GNR-CArg7 have not a significant decrease over time
(Figure 3). This implies that the LPFFD peptide plays an
important role in this interaction. An electrostatic interac-
tion is the main nonspecific interaction mechanism
described for CPPs and the cell membrane. This type of
interaction depends on structural characteristics such as
charge density, epitope length, and chain flexibility.
Interactions with the membrane can cause disruption of
the lipid bilayer organization, either by fusion, fission, or
pore formation, which is an important requirement for
internalization.29,45,46
Further assessments were performed for the interactions
of GNR,GNR-CArg7, and GNR-Arg7CLPFFDwith an S100
monolayer at the air-water interface. Specifically, the GNR-
CArg7 and GNR-Arg7CLPFFD interactions were evaluated
after modification of the S100 isotherm. Figure 4 shows the
Langmuir isotherms and the compressional modulus beha-
vior (Figure 4 inset) of S100 at the air-water interface in the
presence of GNR, GNR-CArg7, and GNR-Arg7CLPFFD in
the aqueous subphase. The compressional modulus was
defined using Equation 1:
Cs1¼Adπ=dA (1)
where Cs−1 is the compressional modulus, π is the surface
pressure, and A is the surface area. Cs−1 has been used to
characterize the mechanical properties of lipid and phos-
pholipid monolayers.36,47,48 It is already known that the
compressional modulus is a very helpful and precise para-
meter to recognize the presence of specific phases and
transition from one phase to another for monolayers at the
air-water interface. Barraza et al48 analyzed the presence of
mixtures with chitosan in stearic acid and cholesterol mono-
layers and found a decrease in the compressional modulus.
It is interesting to mention that at the beginning of the
LE-LC transition, a local maximum of the compressional
modulus was found. Similar behavior was found with
DPPC/bactenecin49 and DPPC/albumin mixtures at the air-
water interface.50 In the present study, the representative
S100 isotherm, which was extracted from soybean oil and
consists of a mixture of three different phospholipids51 is
presented in Figure 4 (solid black line). At large surface
areas, S100 molecules behave as a two-dimensional gas
(> 121 Å2). As compressional barriers reduce the surface
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Figure 3 Percentage fitted peak area GNR and GNR-peptide with liposome over time (0–24 h). (A) 3–5 nm peak and (B) 50 nm peak. Values represent mean ± SEM of
three separate experiments (*p < 0.05).
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area (< 121 Å2), the intermolecular interaction between
S100 molecules becomes important, increasing the π values,
and a liquid expanded (LE) phase is formed.
With continued compression of the S100 phospholipids,
the π-A isotherm does not show a horizontal plateau region
because of the multiple components present in the phospho-
lipid sample, showing a first-order phase transition from LE
to the liquid condensing (LC) phase. The π-A isotherms of
S100 recorded when GNR, GNR-CArg7, or GNR-Arg7
CLPFFD were added into the water subphase show similar
behavior, but they shifted to higher surface areas and
showed an increment of π values. For example, the short
gaseous phase shown by S100 phospholipids disappeared
when GNRs or peptide-conjugated GNRs were introduced
into the subphase. This suggests that GNRs are preadsorbed
on the interface and interact with the S100 components
before surface area compression, and GNRs remain
attached to the S100 monolayer during the whole compres-
sion process. At the end of the LC phase, the phospholipidic
components of S100 are relatively vertically oriented and
closely packed; thus, extrapolating this line region of the
isotherm to zero pressure, the molecular area (A0) can be
attained, where the corresponding value of A0 is the inter-
cepting point of the line that crosses the x-axis. Then, the
A0 values of S100 increased when GNR, GNR-CArg7, and
GNR-Arg7CLPFFD were added to the water subphase from
86 to 90, 92, and 94 Å2, respectively. The surface between
S100 molecules and GNRs can be described by the Cs−1
(Figure 4 inset) parameter, since it gives information about
the lateral interaction that occurs at the air-water interface.
For instance, the progressive increment of Cs−1, observed
from 125 to 82 Å2, indicates strong interactions between
phospholipid components of S100 with GNR, GNR-CArg7,
and GNR-Arg7CLPFFD. Moreover, the high values of Cs
−1
at the end of the compression process (high pressure) sug-
gest that peptide-conjugated GNRs were attached to the
S100 phospholipids and are not expelled from the mono-
layer. These results are in agreement with the previous S100
liposome and oligoarginine conjugated GNR (GNR-CArg7
and GNR-Arg7CLPFFD) interaction study by DLS, sup-
porting that both GNR-CArg7 and GNR-Arg7CLPFFD inte-
grate and stabilize the membrane of the S100 liposomes.
Finally, we mention that the behavior of the compres-
sional modulus of the S100 mixed with GNR and the mix-
tures with the peptides GNR-CArg7 and GNR-Arg7CLPFFD
at higher pressure is contrary to that expected for DPPC and
different mixtures.48–50 There, the compressional modulus
values decreased in comparison with the values for pure
DPPC, producing more compressible monolayers. In con-
trast, as observed in Figure 4, the values of the modulus are
higher than those observed for the pure S100 monolayer.
This could be due to the large number of GNRs attached to
the peptides and/or S100 molecules and to the increase in
electrostatic repulsion, resulting in a more rigid monolayer.
Figure 4 Langmuir isotherms and the compressional modulus (inset figure). Isotherms of the S-100 phospholipid mixture at the air-water interface with GNR, GNR-CArg7
and GNR-Arg7CLPFFD in the aqueous subphase. Isotherms represent the mean with relative error of 2%, n=3. All experiments were performed at 25 °C.
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In addition, as can be observed in the isotherm for S100, the
proportion of DPPC in the monolayer is lower than that used
in,48–50 resulting in different behavior.
To further complement these biophysical studies, cryo-
TEM analysis was performed. Figure 5 shows representa-
tive images of GNR-Arg7CLPFFD with liposomes. At
time 0, the nanoparticles tended to interact with the lipid
membrane, and over time, this interaction increased
(Figure 5, figure S3). After 24 h, the GNR peptides were
arranged in an orderly manner around the liposomes
(Figure 5, Figure S3). These analyses facilitated observa-
tions on how GNRs interact with the S100 lipid mem-
brane. We can suggest that GNR-Arg7CLPFFD interacts
from time zero with liposomes and that most likely the
nanoparticles are organized around the liposome.
Altogether, the applied techniques demonstrated that GNR
conjugation with amphipathic peptides, such as CLPFFD, and
with oligoarginine CPPs enhanced interactions between GNR
and a biological membrane model. First, the positively
charged Arg7 peptide would allow interactions with the nega-
tively charged molecules of biological membranes. Then, the
CLPFFD amphipathic portion would allow the integration
and stabilization of the GNR into the membrane.
Cell Internalization and Viability of GNR,
GNR-CLPFFD, GNR-Arg7CLPFFD, and
GNR-CArg7
To evaluate the improved biophysical properties of peptide-
conjugated GNR, their intracellular localization was studied
in the human neuroblastoma cell line SH-SY5Yusing TEM.
This cell line was chosen for the purpose of directing GNRs
into the brain, which could have future therapeutic
applications. First, the effects of the peptide-conjugated
GNRs on cell viability were evaluated using a colorimetric
method. This method was based on MTS reduction to for-
mazan by mitochondrial enzymes of viable cells; the percent
of MTS reduction is an indicator of cell viability. SH-SY5Y
cells were incubated with different concentrations (0.08,
0.24, and 0.4 nM) of peptide-conjugated GNRs or GNRs
for 24 h. Naked GNRs reduce the cell viability, which could
be attributed to the presence of CTAB (Figure S4), as was
reported previously by our group.21 The CTAB layer present
in the naked GNR can be replaced by CLPFFD or by Arg7
CLPFFD due to the chemisorption of the thiol on the gold
surface reducing the effects on cell viability.
At the studied concentrations, GNR-CLPFFD and
GNR-Arg7CLPFFD did not affect cellular viability
(Figure 6A and B), with the exception of GNR-CArg7,
which reduced the cell viability by 20% (Figure 6C),
which can be considered slight cytotoxicity.52
These results are consistent with those reported by
Morales-Zavala et al, who tested the effects of nanodia-
monds functionalized with R7-CLPFFD on cell viability in
two different cell lines (HT22 hippocampal neurons and
3T3 fibroblast cells) without cytotoxic effects.53 Moreover,
Maiolo et al 2005 demonstrated that the oligoarginine
CPPs R7 and R7W are highly toxic to eukaryotic cells,
in contrast to CPPs rich in arginine and negatively charged
amino acids, such as R7-DTRL and R7W-VQD.54 In this
respect, several studies have assessed the effects of catio-
nic CPPs on cell viability, describing that CPP toxicity is
highly dependent on the sequence, concentration, nature of
the cargo molecule and coupling strategy.54–57
On the other hand, as was also demonstrated by Amani
et al, the functionalization of GNPs with proteins such as
Figure 5 Representative cryo-transmission electronic microscopy image of the interaction of GNR-Arg7CLPFFD with liposomes at different times (0, 3 and 24 h).
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the antibody OX26 can increase the surface charge,
increasing the cytotoxicity. In this respect, the specific
biomedical applications for which the peptide-conjugated
GNR is being designed are very important, and specific
studies are necessary to evaluate each case.58
To study penetrability, the different conjugates were incu-
bated at a concentration of 0.4 nM for 24 h, and the processed
samples were analyzed by TEM. Figure 7 shows representa-
tive TEM microphotographs of cells with, GNR-CLPFFD,
GNR-CArg7, or GNR-Arg7CLPFFD. Figure 7D summarizes
the quantity of GNRs per cell, which were counted for each
condition (25–55 cells per condition). Cells treated with
GNR-Arg7CLPFFD internalized 65% more nanoparticles
(31 ± 7) (Figure 7C and D) than cells treated with
GNR-CLPFFD (11 ± 3) (Figure 7A and D) and 45% more
nanoparticles than cells treated with GNR-CArg7 (17 ± 2)
(Figure 7B and D). Additionally, internalization of the con-
jugates did not induce cell damage. Indeed, all organelles
were easily distinguished and were in good condition, as was
also observed for control cells (Figure S5). Notably, the
conjugates were surrounded by a well-defined membrane
structure that resembled a multivesicular body (Figure 7).
Independent of the cell penetration mechanism of our
nanosystems, the first contact of the oligoarginines with the
cell membrane is through hydrogen bonds with proteogly-
cans, such as heparin sulfate,46 and then the CPPs induced
a structural curvature of the cell membrane for oligoarginine
uptake.46,59
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Figure 6 Cellular viability in SH-SY5Y cells treated with (A) GNR-CLPFFD; (B) GNR-Arg7CLPFFD; and (C) GNR-CArg7 at different concentrations (0.08–0.4 nM) for
24 h. The control was without nanoparticles. The data are expressed as the percent of living cells. Values represent the mean ± SEM of three separate experiments in
triplicate (***p < 0.001).
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Although the focus of our paper is not to study the
penetration mechanism of the GNR to the cells, it is
important to discuss the possible cellular uptake mechan-
isms of CPPs. Nevertheless, there is a consensus that the
endocytic pathway46 has a major role in the internalization
of these peptides; however, in some cases, direct translo-
cation across plasma membranes and cytosolic distribution
of arginine-rich CPPs are still observed in cells without
membrane perturbation.60
The endocytic pathways that contribute to CPP cell
uptake include macropinocytosis and the clathrin and caveo-
lae-dependent pathways.61,62 The most accepted cellular
uptake mechanism of CPP is endocytosis.59 Positive charges
mediate electrostatic interactions between the motifs of
negatively charged lipids and sugars on the outer plasma
membrane, thus promoting internalization.63 On the other
hand, the internalization of nanoparticles mainly occurs
through endocytosis. Consequently, most internalized cargos
are trafficked to an endolysosomal compartment.64 However,
endocytosis-mediated by receptor mechanisms cannot be
discarded due to the interaction of the nanoparticles with
proteins present in the culture medium to form the protein
corona with certain proteins that favor recognition by the
cellular receptors23 gathering the cell internalization.
Our results related to the interaction study by DLS and
Langmuir isotherms supported that GNR-Arg7CLPFFD
enhanced liposomal interactions with respect to GNR-Arg7
and GNR-CLPFFD. The increased interaction with the cell
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Figure 7 Representative TEM images of SH-SY5Y cells incubated with (A) GNR-CLPFFD; (B) GNR-CArg7; (C) GNR-Arg7CLPFFD for 24 h and (D) GNR-peptide per SH-
SY5Y cell, the results represent the mean ± SEM, *p < 0.05 with respect to GNR. Red arrows indicate the presence of nanorods inside the vesicles.
Riveros et al Dovepress
submit your manuscript | www.dovepress.com
DovePress
International Journal of Nanomedicine 2020:151848
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f N
an
om
ed
ici
ne
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
16
1.
11
1.
22
0.
15
9 
on
 1
0-
Ju
n-
20
20
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
membrane would favor subsequent internalization in the
cell. However, further studies should be performed to
study the cell penetration mechanism.
Conclusion
In conclusion, this study demonstrated that GNRs conjuga-
tion with oligoarginines and with amphipathic peptides, such
as CLPFFD, results in enhanced biological membrane inter-
actions. These interactions would be crucial to favor the
further cell penetration. The conjugate GNR-Arg7CLPFFD
does not affect the cell viability. Further experiments should
be performed to analyze the cell penetration mechanism of
GNR-Arg7CLPFFD. Future prospective in vivo studies are
required to establish its potential use for drug delivery.
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